2022 PRESENTING COMPANIES
April 20, 2022 | San Diego, CA
Founder, CEO & CTO
Backed by strong clinical studies and KOL support, Aerolase is a global technology leader in laser skin health and the only manufacturer in the world of portable high-power lasers for aesthetics and dermatology applications. Aerolase delivers a new level of efficacy, safety and patient comfort for a full suite of skin aesthetic and rejuvenation treatments, as well as high efficacy on most widespread dermatological conditions including acne, melasma, psoriasis, onychomycosis. Aerolase has received numerous awards and recognitions in the professional, consumer and media communities, such as the 2021 Holy Grail Awards from Cosmopolitan Magazine in both laser categories: Best Facial Laser and Best Acne Laser.
President & CEO
ALASTIN Skincare® is a complete skin rejuvenation approach that helps to combat fine lines, wrinkles and other visible signs of aging—both our Daily Restorative Skincare and Procedure Support Skincare products are powered by a proprietary technology that supports the production of fresh collagen and elastin, helping to protect and renew skin for a more youthful appearance.
AVAVA has created a new paradigm of focus and precision that doesn’t currently exist in aesthetic laser procedures. Our technology goes beyond anything available today through its pinpoint accuracy and predictable delivery. With our unique 3D technology and proprietary Skin AI visualization, AVAVA has unlocked treatment options for every skin tone. Whether your skin is deep brown, warm beige, pale pink - or any tone in between - our smart energy platform will deliver a highly personalized, safe, and effective treatment. This suite of intelligent and personalized procedures delivers consistent outcomes with less pain and downtime for all patients.
President & CEO
Candesant Biomedical is developing a novel approach to energy production – Targeted Alkali Thermolysis (TAT) – for the non-invasive treatment for excessive sweating. More than half of current aesthetic consumers are bothered by their sweating and Candesant is driving the development and commercialization of a sweat control product utilizing the patented TAT technology to provide a solution that is effective for sweat control while being affordable to the consumer and profitable for the physician.
Candesant’s lead product is a topical patch to treat sweating with a quick, in-office procedure. The TAT technology is based on the principle that alkali metals, in contact with water, generate thermal energy. The company has completed multiple clinical studies, including a successful pivotal trial demonstrating significant sweat reduction benefits lasting up to 3 months after a single, no down-time treatment.
ClearIt has developed an entirely new approach – the ERASER® System – for the healthful, pain-free, inexpensive, single treatment tattoo removal.
Established a global multi-patent position in the novel application of Cold Atmospheric Plasma (CAP) in skin.
Completed (2020) proof of concept in animals – multiple colors removed from multiple animals.
Commenced (2021) proof of feasibility in humans – safety and tolerability studies completed.
Seeking $25M to complete productization of the ERASER® System – timeline is to apply for 510K clearance in 2H 2022; commercial launch in 1H 2023.
Dr. Jasmine Seror
Head of Aesthetic Medicine and Exploratory Products
CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing.
Chief Technology Officer
Cutera is a leading provider of laser and other energy-based systems for dermatologists and aesthetic practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable physicians and other qualified practitioners to offer safe and effective treatments to their patients. For more information, visit www.cutera.com
SVP & General Manager
Our approach stems from more than two decades of pharmaceutical experience, with a heritage of innovation across a spectrum of specialties. The scientific rigor that is part of our DNA is evident in all we do—including leading the largest clinical trials in the history of cellulite investigation in the US.
Exocel Bio is a state-of-the-art biotechnology company leveraging nanoparticles to advance the science of precision growth factors in pursuit of making aesthetics and anti-aging a reality. Designed as a companion product for skin and hair rejuvenation, our line of Exovex aesthetic skincare serums can be used in post-microneedling or energy-based aesthetic applications. The multipotent secretomes in Exovex help reduce the signs of aging by alleviating the stress of modern living and promoting healing for all skin and scalp types.
In 2009, Hair Science was established in the U.S. to further advance the products developed by the Saude group, with the assistance of cosmetic dermatologist and aesthetic surgeon, Dr. Mark Rubin in Beverly Hills, CA and the MasterPharm Compounding Pharmacy in New York. The latest version of the formulation, Formula 82M, is now offered by prescription in the US under license from Hair Science.
CEO & President
We are Jan Marini Skin Research, a San Jose, CA-based company founded in 1994. JMSR is a recognized leader and innovator in skin care that is committed to continually expanding and improving the professional skin care market. JMSR's two primary focuses are to provide innovative technologies that deliver proven measurable results and an unwavering commitment to the ongoing success of our customers.
Bhushan Hardas, MD, MBA
Jeune Inc. is a biotechnology company leveraging a clinically validated gene-delivery platform to fundamentally address – and reverse – the biology of aging or photo-damaged skin.
Jeune was formed in April 2019 by Krystal Biotech to advance a portfolio of innovative treatments that address aesthetic skin conditions. Our product candidates are based on Krystal’s Skin TARgeted Delivery platform, or STAR-D platform. This skin-optimized gene delivery technology enables us to specifically target key cells in the skin for delivery of a desired effector (gene). In doing so, we aim to stimulate a patient’s own cells to produce the important structural proteins that normally decline over time as we age (intrinsic aging) and with photo-damage (extrinsic aging).
Jwala Karnik, MD
EVP, Global Strategy & Partnership
HydraFacial TM Keravive TM is the scalp-health solution to healthier looking hair. The HydraFacial TM Vortex Technology and the KeraviveTM Peptide Complex Solution work together to cleanse, exfoliate, hydrate and nourish the scalp. The KeraviveTM Solution is a concentrated, proprietary blend of biomimetic polypeptides and proteins encased in nano-liposomes. They penetrate the follicles and imitate growth factors that help target scalp and follicle health leading to healthier, thicker-looking hair. A full course of treatment consists of an in-office HydraFacial TM Keravive TM treatment once per month for 3 months, with each treatment followed by home use of the Keravive TM Topical Take-Home Spray.
Lipocube Biotechnology is a medical device company based in London, UK, established to develop, design, and market medical devices based on human fat tissue processing with applications primarily in regenerative medicine. LipocubeTM hybrid technology is the first tissue hybridization system that allows clinicians to obtain concentrated fat tissue with the highest regenerative capacity through a closed and sterile system with minimal manipulation.
Global Leader in HealthWear, simplifying Health and Wellness: #1 Charlotte Business Journal, Deloitte Fast 500 #2 Fastest Growing Pharmaceutical Company in North America, INC. 5000 #50 Fastest Growing Company in America. EY Entrepreneur of the Year Finalist.
Nufabrx is an innovative technology company focused on controlled delivery of active ingredients (vitamin, supplement, medication) through clothing; effective delivery lasts through 15+ wash cycles. Health and wellness reimagined simply by getting dressed in the morning.
We offer a line of topical analgesic infused garments available nationwide at major retailers (Walgreens, CVS, Walmart, Target), as well as a recently launched line of maternity garments infused with Shea Butter to reduce the appearance of stretch marks.
Raziel Therapeutics is a clinical-stage pharmaceutical company developing RZL-012, an injectable New Chemical Entity (NCE), for fat related disorders and Aesthetic indications. RZL-012 exerts its effect via a single multi-injection session in which the compound is injected into subcutaneous fat tissue. The product is capable of killing fat cells, resulting in fat volume reduction and improved dimensions at the treated areas.
Raziel completed enrollment for a US double blind placebo-controlled phase 2b trial (N=150) in subjects seeking submental fat (SMF) reduction. Study results are expected in May 2022. SMF phase 3 studies will initiate by the end of 2022.
Another double blind placebo-controlled phase 2a study is ongoing, testing the effect of RZL-012 on fat reduction in the flanks. Results are expected in July 2022.
Raziel signed a license agreement with Fosun Pharma for RZL-012 commercialization in the big China area.
Caroline (Caro) Van Hove
President & CEO
Revelle Aesthetics is a Silicon Valley-based medtech company focused on medical device innovation to address the root cause of women’s unmet aesthetic needs. The company is committed to developing precision technologies that deliver meaningful results for women and reliable outcomes for physicians. Revelle Aesthetic’s first device, Avéli™, allows physicians to predictably and precisely address cellulite dimples from underneath the skin in a single, in-office treatment. www.revelleaesthetics.com www.myaveli.com
Atta Behfar, MD
RionTM, a clinical-stage regenerative medicine company, is focused on developing innovative exosome therapeutics that are clinically impactful, accessible, and practical for any patient. Rion has developed Purified Exosome ProductTM (PEPTM), an innovative biologic platform that harnesses the therapeutic power of exosomes as a truly shelf-stable allogeneic regenerative medicine. PEP is the foundation of Rion’s therapeutic programs, designed to treat a range of indications where tissue regeneration is needed. The company is currently evaluating PEP for the treatment of wound healing, cardiovascular disease, and pelvic floor disorders.
EVP & Chief Operating Officer
RVL Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing eyecare and medical aesthetics products. The company leverages a unique, fully-integrated business model - which includes its' own pharmacy (RVL Pharmacy) - to modernize self/cash-pay prescription access for patients and providers.
Co-Founder & Managing Partner
Skinbetter Science is one of the aesthetics industry’s fastest growing and most scientifically credentialed professional skincare brands. Following initial market launch in mid-2016, Skinbetter has quickly earned acclaim for its multiple patented technology platforms, award-winning innovative product line, best-in-class customer service, and unmatched channel fidelity. In just five full years of market entry, Skinbetter has already become the largest independent brand in physician-dispensed skincare. Founded by the same executive team that previously established Medicis Pharmaceutical Corp. over three decades as one of the world’s leading pharmaceutical companies in prescription dermatology and medical aesthetics, Skinbetter brings that same clinically rigorous, data-driven orientation to cosmetic skincare. With unique access to global innovation born of the value proposition of an independent firm’s rapid execution together with the credibility of having built multiple iconic aesthetic brands at worldwide scale, the Skinbetter team has curated a diverse R&D pipeline of highly sought-after patented technologies, each designed to solve an unmet medical need in a different skincare category. In addition to its clinical and commercial success, Skinbetter has also earned an important leadership position in the broader aesthetics community – both in public health through the development of the Project AesCert Guidance, designed to facilitate safe aesthetic practice during the pandemic; and in social justice reform through The DREAM Initiative, focused on Driving Racial Equity in Aesthetic Medicine. To learn more, please visit https://skinbetter.com/about/.
President & CEO
Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer Center. Soliton's first FDA cleared commercial product will use rapid pulses of acoustic shockwaves as an accessory to lasers for the removal of unwanted tattoos and the treatment of cellulite. Soliton is based in Houston, Texas, and is actively engaged in bringing the Rapid Acoustic Pulse ("RAP") device to the market. The company believes this "Soliton" method has the potential to lower tattoo removal costs for patients, while increasing profitability to practitioners, compared to current laser removal methods. Soliton is investigating potential additional capabilities of the RAP technology. The device is currently cleared in the United States only for use in tattoo removal and cellulite.
Co-Founder & CEO
Stemson Therapeutics is a preclinical stage company developing a novel cell therapy to regenerate hair follicles to treat Alopecia and various forms of hair loss. Stemson was founded in 2018 based on a unique Induced Pluripotent Stem Cell approach to generate the cell types required to initiate hair growth, which was developed by Stemson cofounder, Alexey Terskikh, PhD, in his lab at the Sanford Burnham Prebys Medical Discovery Institute. The technology has the ability to generate a new supply of hair follicles for patients in need, a capability no other hair loss solution can deliver. The company is headquartered in San Diego, CA and has raised $22.5M in funding led by Allergan Aesthetics, AbbVie Ventures, and DCVC Bio.
Suneva Medical, Inc. is a privately‐held aesthetics company focused on and dedicated to developing, manufacturing and commercializing novel, differentiated products for the regenerative aesthetic markets, meeting the high demand of both physicians and patients.
John Meadors, MD
Ultimate Contour is the only low frequency ultrasound device cleared by the FDA. Our unique ultrasound and radio frequency technologies can provide your patients with a safe, pain-free experience that is effective in reducing the circumference of the abdomen as well as the appearance of cellulite. Patients can see immediate results after just one visit - and even more over time with additional treatments. No consumable costs combined with two separate, but synergistic treatment revenue streams mean a fast return on investment for your practice. It's the perfect solution for anyone who wants to boost their body confidence and for any practice looking to boost their bottom line. Contact us today to schedule your free demonstration!
VP, Business Development